Centessa Pharmaceuticals plc
(NASDAQ: CNTA)
|
8:00 PM UTC, 06/20/25 | |||
---|---|---|---|---|
Last: $12.43 | Change: -0.25 | %Change: -1.97% | Volume: 1,612,616 |
11:15 AM EDT, 06/18/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were edging up on Wednesday morning, up nearly 0.1% to 1,466.83 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by steel producer ArcelorMittal (MT) and bank Banco Bilbao Vizcaya Argentaria (BBVA), which rose 2.3% and 1.6% respectively.
They were followed by bank Banco Santander (SAN), up 1.2%.
The decliners from continental Europe were led by clinical-stage biotechnology firm Abivax (ABVX) and biotech company BioNTech (BNTX), which were shedding 2.2% and 0.1%, respectively.
From the UK and Ireland, the gainers were led by biotech companies Bicycle Therapeutics (BCYC) and Centessa Pharmaceuticals (CNTA), which were rising about 4% and 3.3%, respectively.
They were followed by biotech Autolus Therapeutics (AUTL), up 3%.
The decliners from the UK and Ireland were led by biotech Akari Therapeutics (AKTX) and energy giant BP (BP), which lost 5.1% and 1.6%, respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.